Rabbit Recombinant Monoclonal CRBN antibody. Carrier free. Suitable for WB, IP, Flow Cyt (Intra) and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
ICC/IF | WB | IP | Flow Cyt (Intra) | |
---|---|---|---|---|
Human | Not recommended | Tested | Tested | Tested |
Mouse | Not recommended | Tested | Expected | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Select an associated product type
Substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2, ILF2 or GLUL (PubMed:26990986, PubMed:33009960). Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8 (PubMed:20223979, PubMed:24328678, PubMed:25043012, PubMed:25108355). Maintains presynaptic glutamate release and consequently cognitive functions, such as memory and learning, by negatively regulating large-conductance calcium-activated potassium (BK) channels in excitatory neurons (PubMed:18414909, PubMed:29530986). Likely to function by regulating the assembly and neuronal surface expression of BK channels via its interaction with KCNT1 (PubMed:18414909). May also be involved in regulating anxiety-like behaviors via a BK channel-independent mechanism (By similarity). Plays a negative role in TLR4 signaling by interacting with TRAF6 and ECSIT, leading to inhibition of ECSIT ubiquitination, an important step of the signaling (PubMed:31620128).
AD-006, CRBN, Protein cereblon
Rabbit Recombinant Monoclonal CRBN antibody. Carrier free. Suitable for WB, IP, Flow Cyt (Intra) and reacts with Human, Mouse samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
WB-rat is labelled with inconclusive, since the autoubiquitination of CRBN (around 100 kDa; PMID: 25043012) are found in both cell & tissue WB. There is slightly different from WB-human & mouse.
ab315345 is the carrier-free version of Anti-CRBN antibody [EPR28739-64] ab315344.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
CRBN also known as cereblon is a protein involved in the regulation of protein homeostasis. It has a molecular weight of approximately 51 kDa. CRBN is expressed in various tissues including the brain kidney and muscle. It functions as a substrate receptor for the CRL4-CRBN E3 ubiquitin ligase complex recognizing proteins for ubiquitination and degradation. The chemical structure of thalidomide shows binding affinity to CRBN influencing its function.
Cereblon plays a role in the regulation of protein stability and degradation. It forms part of the CRL4-CRBN complex which tags specific proteins for ubiquitination and subsequent proteasomal degradation. This function is critical for maintaining cellular protein balance. Additionally CRBN modulates immune response and has immunomodulator properties influencing cell-mediated responses.
CRBN participates in the ubiquitin-proteasome pathway which regulates protein turnover and quality control within cells. Moreover CRBN is involved in immune signaling pathways partly by modulating the expression of various cytokines and immune-related proteins. It interacts with proteins such as DDB1 and CUL4 within these pathways impacting cellular responses to stress and immune challenges.
CRBN is associated with multiple myeloma and intellectual disability. Cereblon acts as a target for drugs like thalidomide and lenalidomide which are used in the treatment of multiple myeloma by altering ubiquitination processes. In intellectual disability alterations in CRBN function or expression can disrupt neuronal development and signaling. CRBN interacts with proteins like IKZF1 and IKZF3 within these contexts affecting their roles in disease progression and treatment responses.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-CRBN antibody [EPR28739-64] ab315344, the same antibody clone in a different buffer formulation.
CRBN was immunoprecipitated from 0.35 mg HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate with Anti-CRBN antibody [EPR28739-64] ab315344 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-CRBN antibody [EPR28739-64] ab315344 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 2: Anti-CRBN antibody [EPR28739-64] ab315344 IP in HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-CRBN antibody [EPR28739-64] ab315344 in HeLa whole cell lysate
All lanes: Immunoprecipitation - Anti-CRBN antibody [EPR28739-64] (Anti-CRBN antibody [EPR28739-64] ab315344) at 1/30 dilution
All lanes: HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution
Exposure time: 180s
This data was developed using Anti-CRBN antibody [EPR28739-64] ab315344, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HeLa (human cervical adenocarcinoma epithelial cell) cells labelling CRBN with Anti-CRBN antibody [EPR28739-64] ab315344 at 1/500 dilution (0.1 ug)/Red compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) at 1/5000 dilution was used as the secondary antibody.
This data was developed using Anti-CRBN antibody [EPR28739-64] ab315344, the same antibody clone in a different buffer formulation.
The molecular weight observed around 100 kDa is autoubiquitination of CRBN, which is consistent with what has been described in the literature (PMID: 25043012).
Lanes 1-3 are applied with Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 and lanes 4-9 are applied with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-CRBN antibody [EPR28739-64] (Anti-CRBN antibody [EPR28739-64] ab315344) at 1/1000 dilution
Lane 1: Human hippocampus tissue lysate at 20 µg with 5% NFDM/TBST
Lane 2: Human testis tissue lysate at 20 µg with 5% NFDM/TBST
Lane 3: Human skeletal muscle tissue lysate at 20 µg with 5% NFDM/TBST
Lane 4: Mouse brain tissue lysate at 20 µg with 5% NFDM/TBST
Lane 5: Mouse testis tissue lysate at 20 µg with 5% NFDM/TBST
Lane 6: Mouse skeletal muscle tissue lysate at 20 µg with 5% NFDM/TBST
Lane 7: Rat brain tissue lysate at 20 µg with 5% NFDM/TBST
Lane 8: Rat testis tissue lysate at 20 µg with 5% NFDM/TBST
Lane 9: Rat skeletal muscle tissue lysate at 20 µg with 5% NFDM/TBST
Lanes 1 - 3: Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG (Merck DC03L) at 1/100000 dilution
Lanes 4 - 9: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/2000 dilution
Observed band size: 50 kDa, 36 kDa
Exposure time: 3s
This data was developed using Anti-CRBN antibody [EPR28739-64] ab315344, the same antibody clone in a different buffer formulation.
The molecular weight observed around 100 kDa is autoubiquitination of CRBN, which is consistent with what has been described in the literature (PMID: 25043012).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-CRBN antibody [EPR28739-64] (Anti-CRBN antibody [EPR28739-64] ab315344) at 1/1000 dilution
Lane 1: MOLT-4 (human lymphoblastic leukemia T lymphoblast) whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 2: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 3: U266B1 (human mtiple myeloma B lymphocyte) whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 4: PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 5: HEK-293 (human embryonic kidney epithelial cell) transfected with scrambled siRNA control whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 6: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 7: RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 8: C6 (rat glial tumor glial cell) whole cell lysate at 40 µg with 5% NFDM/TBST
Lane 9: PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate at 40 µg with 5% NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 50 kDa, 36 kDa
Exposure time: 5.5s
This data was developed using Anti-CRBN antibody [EPR28739-64] ab315344, the same antibody clone in a different buffer formulation.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-CRBN antibody [EPR28739-64] (Anti-CRBN antibody [EPR28739-64] ab315344) at 1/1000 dilution
Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg with 5% NFDM/TBST
Lane 2: HeLa transfected with siRNA specifically targeting CRBN whole cell lysate at 20 µg with 5% NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 50 kDa, 36 kDa
Exposure time: 26s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com